Abstract
Analysis of microbiome sampled from a given cancer site can yield information that may serve as a prognostic of exposure, risk, disease progression, and treatment response. We reviewed available published literature, and grants funded by the National Cancer Institute’s Division of Cancer Control and Population Sciences to identify trends and areas for future research. The incorporation of microbiome analysis in epidemiologic studies of cancer is providing some promising insights into risk stratification. However, our analysis identified several knowledge gaps in this emerging field: 1. Limited evidence for the stability of different biospecimen types over time and at given temperatures for microbiome analysis, 2. Analysis software that reliably standardizes sequencing data from different platforms and corrects for biases against rare or unrepresented taxa, 3. Harmonization of methods used for microbiome analysis across research centers. 4. Surrogate markers that will be useful for monitoring disease progression from the time of infection to cancer development, 5. Time-varying microbiome in the natural history of different cancers in order to identify key microbiota or shifts in community structure, and 6. Determining whether the microbiota cause or effect cancer risk and outcomes. If these knowledge gaps are addressed, microbiome analysis is likely to provide the cancer field with new approaches for early diagnosis and help develop more effective preventative measures.
Highlights
The microbiota that colonize various anatomical sites throughout the human body contribute to our overall health through physiologic and metabolic processes necessary for survival
Microbiome is the associated genome of the microbiota and it codes for the necessary processes that are not encoded by the human genome [1]
Trends in the NCI-funded grants are demonstrating a shift to true microbiome analysis in cancer epidemiology, by assessing the overall changes in community structure or function
Summary
The microbiota that colonize various anatomical sites throughout the human body contribute to our overall health through physiologic and metabolic processes necessary for survival. Microbiome is the associated genome of the microbiota and it codes for the necessary processes that are not encoded by the human genome [1]. The microbiota is dynamic; the abundance or functions of certain species within a community can shift or change in response to typical exposures such as: infection, antibiotics, and/or diet. In some cases these shifts propagate disbyosis and dysfunction of microbiota which contribute to disease [6]
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Cancer Research and Molecular Mechanisms ( ISSN 2381-3318 )
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
